EPS HEALTH TECH (03860) announces expected mid-term net profit of approximately HK$16 million, turning losses into gains year-on-year.
EPS Health Technology (03860) announced that the group is expected to record a... for the six months ending September 30, 2024.
EPS Health Tech (03860) announced that the group is expected to achieve unaudited net profit of approximately HK$16 million for the six-month period ending on September 30, 2024, compared to an unaudited net loss of approximately HK$8.7 million for the six-month period ending on September 30, 2023. The expected improvement is mainly attributed to (i) fair value gains on bills of exchange generated by non-controlling interests; (ii) an increase in profits from the healthcare products business; and (iii) a reduction in administrative and research and development expenses due to cost-saving measures implemented by the group.
Related Articles
US Stock Market Move | Micron Technology, Inc.(MU.US) soars more than 14% in pre-market trading, performance guidance greatly exceeds expectations.
On December 18, Tianli International Holdings Limited (01773) spent HK$228,000 to repurchase 100,000 shares.
CARSGEN-B(02171) has repurchased a total of 7.627 million shares, Yijie Consistent Action Group has increased its holdings by 335,000 shares.
US Stock Market Move | Micron Technology, Inc.(MU.US) soars more than 14% in pre-market trading, performance guidance greatly exceeds expectations.
On December 18, Tianli International Holdings Limited (01773) spent HK$228,000 to repurchase 100,000 shares.
CARSGEN-B(02171) has repurchased a total of 7.627 million shares, Yijie Consistent Action Group has increased its holdings by 335,000 shares.
